Antiarrhythmic drugs 2013: state of the art.

Abstract:

:Antiarrhythmic drugs are widely used, but are of modest efficacy and have important side effects. However, even with the advance of catheter ablation for atrial fibrillation and ventricular tachycardia, antiarrhythmic drugs remain an important tool for treating arrhythmias. Antiarrhythmic drug development has remained slow despite much effort given our limited understanding of what role various ionic currents play in arrhythmogenesis and how they are modified by arrhythmias. This review will focus on promising new antiarrhythmic drugs undergoing clinical investigation or currently approved for clinical use, including amiodarone analogues, agents with novel ionic targets, and new drug combinations.

journal_name

Curr Cardiol Rep

authors

Kumar K,Zimetbaum PJ

doi

10.1007/s11886-013-0410-2

subject

Has Abstract

pub_date

2013-10-01 00:00:00

pages

410

issue

10

eissn

1523-3782

issn

1534-3170

journal_volume

15

pub_type

杂志文章,评审
  • Sudden cardiac death without structural heart disease: update on the long QT and Brugada syndromes.

    abstract::The long QT syndrome (LQTS) and the Brugada syndrome (BrS) are the most common genetic causes of malignant ventricular arrhythmias and sudden cardiac death in young patients with normal cardiac morphology. To date, more than 250 different mutations in seven genes have been identified as causing LQTS, whereas the only ...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-005-0088-1

    authors: Goldenberg I,Moss AJ,Zareba W

    更新日期:2005-09-01 00:00:00

  • Subclinical cardiovascular disease assessment in persons with diabetes.

    abstract::Patients with diabetes mellitus are at particularly high risk for cardiovascular disease. Although global risk factor scoring systems, such as the Framingham Risk Score, are well established for screening asymptomatic adults, they are not as predictive in diabetics. Therefore, there has been considerable interest in n...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-013-0358-2

    authors: Warraich HJ,Nasir K

    更新日期:2013-05-01 00:00:00

  • Genetic determinants of drug response in heart failure.

    abstract::Heart failure management is complex and costly. Genetic variations that alter drug absorption, metabolism, and receptor-ligand interactions have the potential to modify drug response and safety. Evidence shows that genetic factors interact with numerous heart failure medications, including vasodilators, beta blockers,...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-008-0031-3

    authors: Lowes BD,Buttrick PM

    更新日期:2008-05-01 00:00:00

  • Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.

    abstract:PURPOSE OF REVIEW:The two most common types of cardiac amyloidosis are caused by fibril deposits of immunoglobulin light chains (AL) and transthyretin (TTR), each with distinct prognosis and clinical management. Cardiac amyloidosis is under-recognized among heart failure patients with preserved ejection fraction (HFpEF...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-018-0970-2

    authors: Chen W,Ton VK,Dilsizian V

    更新日期:2018-03-08 00:00:00

  • Prognostic Biomarkers in Acute Coronary Syndromes: Risk Stratification Beyond Cardiac Troponins.

    abstract:PURPOSE OF REVIEW:Cardiac troponin (cTn) plays an essential role for assessment of outcome in acute coronary syndrome (ACS). However, the prognostic value of cTn is not absolute. In this mini-review, we summarize the evidence on the utility of established biomarkers of left-ventricular dysfunction, hemodynamic stress, ...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-017-0840-3

    authors: Eggers KM,Lindahl B

    更新日期:2017-04-01 00:00:00

  • Global risk assessment for lipid therapy to prevent coronary heart disease.

    abstract::Randomized clinical trials have established that lipid- lowering pharmacologic therapy can substantially reduce morbidity and mortality in patients with known coronary artery disease (CAD). Researchers are now working to define the role of lipid-lowering agents in the primary prevention of CAD to extend their benefit ...

    journal_title:Current cardiology reports

    pub_type: 杂志文章

    doi:10.1007/s11886-000-0056-8

    authors: Nass CM,Wiviott SD,Allen JK,Post WS,Blumenthal aR

    更新日期:2000-09-01 00:00:00

  • Emerging inflammatory markers for assessing coronary heart disease risk.

    abstract::Although assessment of traditional coronary heart disease risk factors can often stratify individuals into low- or high-risk categories, additional means are needed to more precisely classify people clinically defined as intermediate-risk, to guide the intensity of risk-reducing therapies. The recognition that inflamm...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-009-0065-1

    authors: Corson MA

    更新日期:2009-11-01 00:00:00

  • Is too much neurohormonal blockade harmful?

    abstract::A number of neurohormones and cytokines are activated in heart failure and their activity is related to the progression of heart failure. Inhibiting the deleterious effects of the activated sympathetic and the renin-angiotensin-aldosterone systems with b-blockers, angiotensin-converting enzyme inhibitors, and aldoster...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-004-0019-6

    authors: Anand IS

    更新日期:2004-05-01 00:00:00

  • Imaging Approaches for Coronary Artery Anomalies: Purpose and Techniques.

    abstract:PURPOSE OF REVIEW:Comprehensive discussion of alternative techniques in imaging coronary artery anomalies (CAAs) in different diagnostic scenarios. RECENT FINDINGS:At primary screening, intramural course essentially correlates with stenosis and clinical repercussion in some types of CAAs. Potential clinical aims in im...

    journal_title:Current cardiology reports

    pub_type: 杂志文章

    doi:10.1007/s11886-019-1188-7

    authors: Angelini P

    更新日期:2019-07-29 00:00:00

  • Utilizing risk scores in determining the optimal revascularization strategy for complex coronary artery disease.

    abstract::Percutaneous coronary intervention (PCI) of multivessel and/or left main stem disease have been shown to be potentially legitimate revascularization alternatives in appropriately selected patients. Risk stratification is an important component in guiding patients to identify the most appropriate revascularization moda...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-011-0202-5

    authors: Farooq V,Brugaletta S,Serruys PW

    更新日期:2011-10-01 00:00:00

  • Hypertension in black patients: special issues and considerations.

    abstract::The excess risk of hypertension in black Americans continues to be a major health concern. Although there is considerable information regarding these disease trends, much of the major underpinnings of the etiology of hypertension remain unclear. The excess mortality in blacks due to heart disease, renal failure, and s...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-004-0048-1

    authors: Nesbitt SD

    更新日期:2004-11-01 00:00:00

  • Antithrombotic strategies in gene therapy.

    abstract::Advances in the field of molecular medicine are making gene therapy a viable treatment strategy for the next millennium. Indeed, over the past 10 years, a number of improvements have occurred that have resulted in an increased interest in gene therapy for the treatment of diseases in cardiovascular medicine. Because a...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-000-0023-4

    authors: Channon KM,Annex BH

    更新日期:2000-01-01 00:00:00

  • Spontaneous Coronary Artery Dissection.

    abstract::Spontaneous coronary artery dissection is an important etiology of nonatherosclerotic acute coronary syndrome, myocardial infarction, and sudden death. Innovations in the catheterization laboratory including optical coherence tomography and intravascular ultrasound have enhanced the ability to visualize intimal disrup...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-016-0737-6

    authors: Tweet MS,Gulati R,Hayes SN

    更新日期:2016-07-01 00:00:00

  • Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Treatment of Unprotected Left Main Stenosis.

    abstract:PURPOSE OF REVIEW:This article reviews the latest data on unprotected left main (ULM) percutaneous coronary intervention (PCI) versus coronary artery bypass graft (CABG) surgery, with a focus on the NOBLE and EXCEL trials. RECENT FINDINGS:In EXCEL trial, the primary endpoint at 3 years was 15.4% in the PCI group and 1...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-019-1113-0

    authors: Taha Y,Patel RAG,Bagai J,Sachdeva R,Kumar G,Prasad A,Nathan S,Paul TK

    更新日期:2019-03-18 00:00:00

  • Redefining the role of cardiovascular imaging in patients with pulmonary arterial hypertension.

    abstract::While pulmonary arterial hypertension is a disease primarily affecting the pulmonary vasculature, the right ventricle plays an integral part in the disease process. Although widely used, two-dimensional echocardiography is limited in visualizing the right ventricle and, therefore, assessment of its structure and funct...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-012-0253-2

    authors: Freed BH,Patel AR,Lang RM

    更新日期:2012-06-01 00:00:00

  • Endocardial pacing: the wave of the future?

    abstract::Cardiac resynchronization therapy (CRT) is a proven treatment for heart failure and requires the implantation of a left ventricular (LV) lead, usually placed in a tributary of the coronary sinus. Encouraged by the fact that approximately 30 % of the patients receiving CRT do not benefit from this therapy, LV endocardi...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-012-0298-2

    authors: Bordachar P,Ploux S,Lumens J

    更新日期:2012-10-01 00:00:00

  • Fibrinolytic function and coronary risk.

    abstract::Plasminogen activation potential in the blood is controlled by an equilibrium between plasminogen activators, mainly tissue-type plasminogen activator (t-PA), and inhibitors, mainly plasminogen activator inhibitor (PAI)-1. In cardiovascular practice, imbalance of this fibrinolytic potential is encountered primarily in...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-999-0069-x

    authors: Juhan-Vague I,Morange P,Christine Alessi M

    更新日期:1999-07-01 00:00:00

  • Primary prevention of sudden cardiac death.

    abstract::Sudden cardiac death (SCD) is the leading cause of death in the United States. Although SCD occurs most commonly in patients with established heart disease, SCD can also be the initial manifestation of cardiovascular disease. Efforts to reduce the incidence of SCD include aggressive treatment of heart disease and its ...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-004-0036-5

    authors: Ganz LI

    更新日期:2004-09-01 00:00:00

  • The Lotus Valve System: an In-depth Review of the Technology.

    abstract:PURPOSE OF REVIEW:Innovation for transcatheter aortic valve replacement (TAVR) has transformed a medically complex treatment into a standardized procedure. While Edwards SAPIEN and Medtronic CoreValve occupy the market for TAVR in the United States (US), additional valve systems are being developed. The Boston Scientif...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-019-1234-5

    authors: Seigerman ME,Nathan A,Anwaruddin S

    更新日期:2019-11-25 00:00:00

  • Use of cardiac magnetic resonance to assess viability.

    abstract::The accurate differentiation of viable and nonviable myocardium is crucial for therapy planning in patients with coronary artery disease and left ventricular dysfunction. Traditional techniques such as echocardiography, positron emission tomography, single photon emission computed tomography, and dobutamine echocardio...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-005-0012-8

    authors: Wagner A,Mahrholdt H,Kim RJ,Judd RM

    更新日期:2005-01-01 00:00:00

  • Noninvasive assessment of coronary artery disease in women: What's next?

    abstract::Significant progress in research has been made in the areas of sex-specific aspects of cardiovascular disease. Despite these advances, coronary artery disease (CAD) is the leading cause of death of women in the Western world. Over the past decade, the focused research on women at risk for ischemic heart disease has he...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-010-0084-y

    authors: Phillips LM,Mieres JH

    更新日期:2010-03-01 00:00:00

  • Should Angiotensin-Converting Enzyme Inhibitors ever Be Used for the Management of Hypertension?

    abstract:PURPOSE OF REVIEW:Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are commonly used anti-hypertensive medications in a number of clinical settings. They are often used interchangeably, but we pose the provocative question as to whether they should be. We review the literature to evaluate for ...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-020-01352-8

    authors: Turner JM,Kodali R

    更新日期:2020-07-09 00:00:00

  • Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy.

    abstract:PURPOSE OF REVIEW:This review discusses the complementary roles of echocardiography and cardiac magnetic resonance in the diagnosis and management of patients with hypertrophic cardiomyopathy (HCM). RECENT FINDINGS:Imaging using novel echocardiographic techniques and cardiac magnetic resonance (CMR) imaging in HCM has...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-017-0897-z

    authors: Hindieh W,Chan R,Rakowski H

    更新日期:2017-09-01 00:00:00

  • PCSK9 Inhibitors: Treating the Right Patients in Daily Practice.

    abstract:PURPOSE OF REVIEW:Monoclonal antibodies that inhibit proprotein convertase subtilisin/kexin type 9 (PCSK9) have emerged as a novel approach to low-density lipoprotein cholesterol (LDL-C) lowering. The potential role of PCSK9 inhibitors in clinical practice will be reviewed. RECENT FINDINGS:Clinical trials have demonst...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-017-0882-6

    authors: King P,Nicholls SJ

    更新日期:2017-08-01 00:00:00

  • Management of Hypertension in Children and Adolescents.

    abstract::Hypertension in children and adolescents is becoming a greater problem in the developed world. Although traditionally thought of as usually secondary to renal, vascular, or endocrine causes, primary hypertension is becoming the most common form seen in childhood. This changing epidemiology is related to the recent obe...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-015-0661-1

    authors: Samuels J,Bell C,Samuel J,Swinford R

    更新日期:2015-12-01 00:00:00

  • Rationale and Current Evidence for Testing Iron Chelators for Treating Stroke.

    abstract:PURPOSE OF REVIEW:To discuss the mechanisms of iron regulation in the brain and the pathophysiological role of deregulation of iron homeostasis following a stroke, and to review existing evidence supporting the potential role of iron chelators in the treatment of ischemic and hemorrhagic stroke. RECENT FINDINGS:In rec...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-019-1106-z

    authors: Hanafy KA,Gomes JA,Selim M

    更新日期:2019-03-04 00:00:00

  • The impact of atrial fibrillation and its treatment on dementia.

    abstract::Atrial fibrillation (AF) is a very common tachyarrhythmia and is becoming increasingly prevalent, while dementia is a neurological condition manifested as loss of memory and cognitive ability. Both these conditions share several common risk factors. It is becoming increasingly evident that AF increases the risk of dem...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-014-0519-y

    authors: Kanmanthareddy A,Vallakati A,Sridhar A,Reddy M,Sanjani HP,Pillarisetti J,Atkins D,Bommana S,Jaeger M,Berenbom L,Lakkireddy D

    更新日期:2014-08-01 00:00:00

  • Bivalirudin for percutaneous coronary intervention and in acute coronary syndromes.

    abstract::This review focuses on the use of bivalirudin as a replacement anticoagulant for heparin in patients undergoing percutaneous coronary intervention, or who are being treated for unstable angina pectoris, ST-elevation, or non-ST-elevation myocardial infarction. Potential advantages of bivalirudin include a lack of depen...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-001-0050-9

    authors: Bates ER

    更新日期:2001-09-01 00:00:00

  • Autonomic Modulation in Heart Failure: Ready for Prime Time?

    abstract::It has been known for many decades that multiple abnormalities of the autonomic nervous system (ANS) are present in heart failure (HF). Moreover, many of the effective therapies currently used to treat HF have either direct or indirect effects on the ANS. While therapies that block over-activity of the sympathetic ner...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-015-0652-2

    authors: Dunlap ME,Bhardwaj A,Hauptman PJ

    更新日期:2015-11-01 00:00:00

  • Direct thrombin inhibitors as adjuncts to thrombolytic therapy.

    abstract::Thrombolytic therapy aims to achieve rapid and sustained infarct-related artery patency, although this results in a procoagulant state. Heparin has limitations as an antithrombin agent, which has led to clinical investigation of alternative agents. Direct thrombin inhibitors, as adjuncts to thrombolytic therapy, have ...

    journal_title:Current cardiology reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11886-999-0021-0

    authors: French JK,White HD

    更新日期:1999-09-01 00:00:00